The Global Alliance for TB Drug Development (TB Alliance) is a nonprofit biopharmaceutical group based in New York that develops medicines for tuberculosis. Its lobby filings show it seeks federal budget and appropriations funding, asking Congress to support fiscal-year 2026 funding for TB programs at the Department of Defense, the National Institutes of Health, and the U.S. Agency for International Development. The group has reported $80,000 in lobbying across four filings and used the Cavarocchi Ruscio Dennis firm.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ERIN WILL MORTON
The latest disclosures for this client.
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Q3CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
ms GRACE KELLEY KRANSTOVER
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Q1CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Q4CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Q3CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Q2CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Q1